AFF3 is a Prognostic Biomarker Correlated with Immune Infiltrates in Triple-Negative Breast Cancer
Background: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer that cannot be treated with targeted therapies such as endocrine therapy or anti-HER-2 (anti-human epidermal growth factor receptor 2) therapy. In the growth of tumors, AFF3 (AF4/FMR2 family member 3) plays a cri...
Saved in:
| Main Authors: | Jing Chen, Bing Tan, Wei Zhuang, Tenghua Yu, Jianglong Li, Chongwu He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2023-08-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/50/8/10.31083/j.ceog5008165 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01) -
Predicting survival in bladder cancer with a novel apoptotic gene-related prognostic model
by: Ding-ming Song, et al.
Published: (2024-11-01) -
Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancer
by: Yimin Zhu, et al.
Published: (2025-02-01) -
Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer
by: Eunkyung Han, et al.
Published: (2024-12-01) -
Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer
by: A. F. Nasretdinov, et al.
Published: (2020-06-01)